PRE 14A

PRE 14A

Company: Tonix Pharmaceuticals Holding Corp.
Filed: April 17, 2017
Period of Report: April 17, 2017
Accession Number: 0001615774-17-001730

View Document ↗ View on SEC.gov ↗